Understanding young peoples’ and family members’ views of treatment for first episode psychosis in a randomised controlled trial (MAPS)

Understanding young peoples’ and family members’ views of treatment for first episode psychosis in a randomised controlled trial (MAPS)

Background: There is limited evidence to inform treatment decision-making in adolescents experiencing first episode psychosis (FEP). In the MAPS trial (Managing Adolescent first Episode Psychosis: a feasibility Study), adolescents with FEP received either antipsychotic medication (AP), psychological...

Täydet tiedot

Bibliografiset tiedot
Päätekijät: R.E. Byrne, J.C. Bird, S. Reeve, W. Jones, D. Shiers, A.P. Morrison, M. Pyle, S. Peters
Aineistotyyppi: Artikkeli
Kieli:English
Julkaistu: Elsevier 2020-07-01
Sarja:EClinicalMedicine
Aiheet:
Qualitative
Child
Adolescent
Family
Psychosis
Antipsychotic medicaiton
Linkit:http://www.sciencedirect.com/science/article/pii/S2589537020301619

Internet

http://www.sciencedirect.com/science/article/pii/S2589537020301619

Samankaltaisia teoksia